4.7 Article Proceedings Paper

Innovations and Challenges in Renal Cancer: Summary Statement From the Third Cambridge Conference

Journal

CANCER
Volume 115, Issue 10, Pages 2247-2251

Publisher

WILEY
DOI: 10.1002/cncr.24229

Keywords

renal cancer; genetics; vascular endothelial growth factor; immunotherapy; biomarkers

Categories

Funding

  1. Intramural NIH HHS [Z01 SC006659-25] Funding Source: Medline

Ask authors/readers for more resources

The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow. Cancer 2009;115(10 suppl):2247-51. (C) 2009 American Cancer Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available